Tim Harrison

3.8k total citations · 1 hit paper
70 papers, 2.2k citations indexed

About

Tim Harrison is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tim Harrison has authored 70 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Physiology, 45 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Tim Harrison's work include Asthma and respiratory diseases (52 papers), Respiratory and Cough-Related Research (32 papers) and Inhalation and Respiratory Drug Delivery (21 papers). Tim Harrison is often cited by papers focused on Asthma and respiratory diseases (52 papers), Respiratory and Cough-Related Research (32 papers) and Inhalation and Respiratory Drug Delivery (21 papers). Tim Harrison collaborates with scholars based in United Kingdom, United States and Sweden. Tim Harrison's co-authors include Anne E. Tattersfield, Helen K. Reddel, Kevin Mortimer, Richard Hubbard, Marc Humbert, Paul M. O’Byrne, Christine Jenkins, Santiago Quirce, Eric D. Bateman and Malcolm R. Sears and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Tim Harrison

66 papers receiving 2.1k citations

Hit Papers

Controlled Trial of Budesonide–Formoterol as Needed for M... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Harrison United Kingdom 27 1.6k 1.5k 224 214 178 70 2.2k
Colin Reisner United States 22 2.2k 1.4× 2.4k 1.6× 305 1.4× 153 0.7× 71 0.4× 122 3.0k
Ronina Covar United States 29 2.8k 1.7× 2.5k 1.6× 337 1.5× 198 0.9× 198 1.1× 74 3.3k
Claes-Göran Löfdahl Sweden 14 2.1k 1.3× 2.5k 1.7× 189 0.8× 87 0.4× 120 0.7× 16 2.9k
Philip W. Ind United Kingdom 23 1.2k 0.8× 1.3k 0.9× 186 0.8× 182 0.9× 112 0.6× 66 2.1k
T Kava Finland 16 2.5k 1.5× 2.0k 1.4× 389 1.7× 192 0.9× 167 0.9× 20 3.0k
Adel Mansur United Kingdom 25 2.0k 1.2× 1.6k 1.0× 358 1.6× 312 1.5× 71 0.4× 88 2.4k
N M Wilson United Kingdom 22 1.2k 0.7× 1.2k 0.8× 143 0.6× 59 0.3× 154 0.9× 35 1.7k
Andrea Zanini Italy 20 785 0.5× 1.1k 0.7× 81 0.4× 351 1.6× 98 0.6× 38 1.8k
Christina Gratziou Greece 26 1.3k 0.8× 841 0.6× 305 1.4× 225 1.1× 132 0.7× 55 2.0k
B Stenius-Aarniala Finland 13 1.9k 1.2× 1.5k 1.0× 257 1.1× 251 1.2× 182 1.0× 29 2.5k

Countries citing papers authored by Tim Harrison

Since Specialization
Citations

This map shows the geographic impact of Tim Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Harrison more than expected).

Fields of papers citing papers by Tim Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Harrison. The network helps show where Tim Harrison may publish in the future.

Co-authorship network of co-authors of Tim Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Harrison. A scholar is included among the top collaborators of Tim Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Harrison. Tim Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kerkhof, Marjan, Tham Le, Tim Harrison, et al.. (2025). Adherence to inhaled corticosteroid medications after an asthma exacerbation and the risk of subsequent exacerbations. Annals of Allergy Asthma & Immunology. 136(2). 160–167.e4.
4.
Foster, Juliet M., Richard Beasley, Irene Braithwaite, et al.. (2022). Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study. BMJ Open. 12(1). e048537–e048537. 9 indexed citations
5.
Shaw, Karen Joy, Nicola Singleton, Tricia M. McKeever, et al.. (2021). A low exhaled nitric oxide level excludes a short‐term benefit from inhaled corticosteroids in suspected asthma: A randomized placebo‐controlled trial. Respirology. 26(7). 666–672. 6 indexed citations
6.
Harrison, Tim, Giorgio Walter Canonica, Geoffrey Chupp, et al.. (2020). Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis. European Respiratory Journal. 56(4). 2000151–2000151. 91 indexed citations
8.
Beasley, Richard, Mark Holliday, Helen K. Reddel, et al.. (2019). Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma. New England Journal of Medicine. 380(21). 2020–2030. 266 indexed citations breakdown →
9.
Johnston, Sebastian L., Mátyás Szigeti, Mary Cross, et al.. (2016). A Randomised, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy Of Oral Azithromycin (500 Mg Od) As A Supplement To Standard Care For Adult Patients With Acute Exacerbations Of Asthma (the Azalea Trial). Spiral (Imperial College London). 1 indexed citations
10.
Hodgson, David, John R. Anderson, Catherine Reynolds, et al.. (2016). The Effects of Azithromycin in Treatment-Resistant Cough. CHEST Journal. 149(4). 1052–1060. 37 indexed citations
11.
McKeever, Tricia M., Glenn Hearson, Gemma Housley, et al.. (2015). Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study. Thorax. 71(3). 210–215. 50 indexed citations
12.
John, Michelle, Jeremy K. Cockcroft, Tricia M. McKeever, et al.. (2015). Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial. International Journal of COPD. 10. 211–211. 21 indexed citations
13.
Djukanović, Ratko, Tim Harrison, Sebastian L. Johnston, et al.. (2014). The Effect of Inhaled IFN-β on Worsening of Asthma Symptoms Caused by Viral Infections. A Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 190(2). 145–154. 198 indexed citations
14.
Bateman, Eric D., Roland Buhl, Paul M. O’Byrne, et al.. (2014). Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations. Journal of Allergy and Clinical Immunology. 135(6). 1457–1464.e4. 75 indexed citations
15.
Negm, Ola H., et al.. (2014). Development and Validation of Protein Microarray Technology for Simultaneous Inflammatory Mediator Detection in Human Sera. Mediators of Inflammation. 2014. 1–12. 27 indexed citations
16.
O’Byrne, Paul M., Helen K. Reddel, Göran Eriksson, et al.. (2010). Measuring asthma control: a comparison of three classification systems. European Respiratory Journal. 36(2). 269–276. 65 indexed citations
17.
Oborne, Janet, Kevin Mortimer, Richard Hubbard, Anne E. Tattersfield, & Tim Harrison. (2009). Quadrupling the Dose of Inhaled Corticosteroid to Prevent Asthma Exacerbations. American Journal of Respiratory and Critical Care Medicine. 180(7). 598–602. 74 indexed citations
19.
Mortimer, Kevin, Anne E. Tattersfield, Yufei Tang, et al.. (2007). Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. British Journal of Clinical Pharmacology. 64(4). 439–444. 27 indexed citations
20.
Hubbard, Richard, C. J. P. Smith, Liam Smeeth, Tim Harrison, & Anne E. Tattersfield. (2002). Inhaled Corticosteroids and Hip Fracture: A Population-based Case–Control Study. American Journal of Respiratory and Critical Care Medicine. 166(12). 1563–1566. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026